Survival rate and average age of the patients with breast cancer in Iran: Systematic review and meta-analysis

Journal of Babol University of Medical Sciences

Volumn 18, Issue 8, 2016, Pages 29-40

  YektaKooshali, M H ^a   Bandboni, M Esmaeilpour ^b   Sharami, H ^c   Alipour, Z ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Age; Breast; Cancer; Iran; Meta analysis; Neoplasm; Survival rate; Systematic review

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; FEMALE; HUMAN; IRAN; META ANALYSIS; PUBLICATION; SCIENTIFIC LITERATURE; SURVIVAL RATE; SYSTEMATIC REVIEW;

EID: 84992028953     PISSN: 15614107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (104)

1. Screening for Breast Cancer. WHO; 2016. Available from: http://www.who.int/cancer/detection/breastcancer/en/.
2. Mousavi S, Montazeri A, Mohagheghi M, Jarrahi A, Harirchi I, Najafi M, et al. reast cancer in Iran: an epidemiological review. Breast J. 2007;13(4):383-91.
3. Parkin D, Läärä E, Muir C. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer. 1988;41(2):184-97.
4. Mahboobi A, Alvandi S, Alizadeh Navaei R. An analytical survey on breast lesions in mammography. J Babol Univ Med Sci. 2004;6(2):52-5.[In Persian].
5. Dean T, Armando E. Breast cancer. novak, Berek J, editors. Novak’s gynecoloy.13th.Philadelphia: Lippincott William & Wilkins; 2002.
6. Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast: Wolters Kluwer,5th. United States: Health; 2014.
7. Aghajani H EK, Goya M, Ramezani R, Modirian M, NADALI F. National cancer registry report 2008. Center Dis Control.2011.
8. Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
9. Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A. Breast cancer in Iran: a review of 903 case records. Pub Health. 2000;114(2):143-5.
10. Winer EP, Morrow M, Osborn CK, Harris JR. Chapter 37:Cancer of the breast in Devita Jr VT, Helman S, Rosennberg SA. Cancer principles and practice of oncology.6th.Williams and Wilkins lippincott: Philadelphia, 2001.
11. Hortobagyi GN, de la Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, et al. The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer. 2005;6(5):391-401.
12. YektaKooshali M, Esmaeilpour-Bandboni M, Ramezani A, editors. The Scientific Production and Mapping of researchers in Breast Cancer during 1985- 2015 in Iran in Web of Sciences. 11th International Breast Cancer; 2016: 11th International Breast Cancer: http://ibcc.sbmu.ac.ir/uploads/454_3334_1456829171552_1394.pdf.
13. Kelsey J. A review of the epidemiology of human breast cancer.Epidemiol Rev. 1979;1(1):74-109.
14. Amini Sani N, Shamshir Garan M, Ghavam Nasiri M, Setayesh Y. The effect of active and passive smoking associated with breast cancer. J Babol Univ Med Sci. 2005;7(1):63-8.[In Persian].
15. Hajian K, Gholizadehpasha A, Bozorgzadeh S. Association of obesity and central obesity with breast cancer risk in pre and postmenopausal women. J Babol Univ Med Sci. 2013;15(3):7-15.[In Persian].
16. Yaghmaei S, Bani Hashemi G, Ghorbani R. Survival rate following treatment of primary breast cancer in Semnan, Iran (1991-2002). Koomesh. 2008;9(2):111-6.[In Persian].
17. Bland KI, Beenken SW, Copeland EM, The Breasts In: Brunicardi FC, Anderson DK, Billear TR, Dunn DL, Hunter JG, Pollock RE,editors. Schwartz’s Principles of Surgery, 8th. New York: McGraw-Hill; 2005;453-99.
18. Iglehart JD, Kaelin CM, Diseases of the breast. In: Townsend CM, editor. Sabiston textbook of surgery, the biological basis of modern surgical practice. 6th. Philadelphia: WB Saunders;2001.p.555-90.
19. Hajizadeh N, Pourhoseingholi M, Emadedin M, Baghestani A, Fazeli Z. Incidence Rate of Breast Cancer In Iranian Women, Trend Analysis From 2003 to 2009. Int J Pharma Biomed Sci. 2015;4(3):107-12.
20. Vahdaninia M, Harirchi A, Montazeri A. Evaluation of 5-year survival in women with breast cancer who referred to Imam Khomeini hospital: a prospective study. Payesh Health Monit. 2003;2(2):141-8.[In Persian].
21. Albain K, Allred D, Clark G. Breast cancer outcome and predictors of outcome: are there age differentials?.J Natl Cancer Inst Monogr. 1994;16:35-42.
22. Walker R, Lees E, Webb M, Dearing S. Breast carcinomas occurring in young women 35 years are different. Br J Cancer. 1996;74(11):1796-800.
23. Komran N, Jensen M, Wohlfahrt J, Mouridsen H, Anderson P, Melbye M. Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ. 1998;320(7233):447-9.
24. Edison M, Becker T, Wiggins C. Breast cancer among hispanics, American Indian and non hospanic whites in New Mexico. Int J Epidemiol. 1994;23(2):231-6.
25. Boyer-Chammard A, Taylor TH, Anton-Culver H. Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detect Prev. 1999;23(6):463-73.
26. Byrne C, Smart C, Chu K, Hartman W. Survival advantage differences by age. Evaluation of the extended follow-up of the breast cancer detection demonstration project. Cancer. 1994;74(1):301-10.
27. Nab H, Hop W, Crommelin M, Kluck H, Vander Heijden L, Coeberg J. Changes in long term prognosis for breast cancer in a Dutch cancer registr. BMJ. 1994;309(6947):83-6.
28. Bunderd NJ. Prognostic and predictive factors in breast cancer.Cancer Treat Rev. 2001;27(3):137-42.
29. Fernö M. Prognostic factors in breast cancer: a brief review. Anticancer Res. 1998;18(3C):2167-71.
30. Tabar L, Duffy S, Vitak B, Chen H, Prrevost T. The natural history of breast carcinoma: what have we learned from screening?. Cancer. 1999;86(3):449-53.
31. Treves N, Holleb A. A report of 549 cases of breast cancer in women 35 years of age or younger. J Am Coll Surg. 1958;109(3):271-83.
32. Nugent P, O’Connell T. Breast cancer and pregnancy. Arch Surg. 1985;120(11):1221-4.
33. Saffari M, Sanaeinasab H, Pakpour A. How to Do a Systematic Review Regard to Health: A Narrative Review. J Health Edu Health Promot. 2013;1(1):51-61.
34. Liberati A, Taricco M. How to do and report systematic reviews and meta-analysis. In Franchignoni F. Research in Physical & Rehabilitation Medicine. Pavia: Maugeri Foundation Books; 2010, p. 137-164.
35. Cook D, Mulrow C, Haynes R. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med. 1997;126:376-80.
36. Fallahzadeh H, Momayyezi M, Akhundzardeini R, Zarezardeini S. Five year survival of women with breast cancer in Yazd. Asian Pac J Cancer Prev. 2014;15(16):6597-601.
37. Yarhusseini A, Sharifzadeh L, Delpisheh A, Veisani Y, Sayehmiri F, Sayehmiri K. Survival rates for Esophageal cancer in Iran:a systematic review and meta-analysis. Iran J Cancer Prev. 2014;7(2):61-5.
38. Movahedi M, Haghighat S, Khayamzadeh M, Moradi A, Ghanbari-Motlagh A, Mirzaei H, et al. Survival rate of breast cancer based on geographical variation in iran, a national study. Iran Red Crescent Med J. 2012;14(12):798-804.
39. Akbari M, Mirzaei H, Soori H. 5 year survival of breast cancer in Shohada-e- Tajrish and Jorjani hospitals. Hakim Res J. 2006;9(2):39-44.[In Persian].
40. Fouladi N, Amani F, Harghi Afshan S, Nayebyazdi N. Five year survival of women with breast cancer in Ardabil, north-west of Iran. Asian Pac J Cancer Prev. 2011;12(7):1799-801.
41. Haghighat S. Survival rate and its correlated factors in breast cancer patients referred to Breast Cancer Research Center. Iran J Breast Dis. 2013;6(3):28-36.[In Persian].
42. Makarian F, Makarian S, Ramezani A. Relations of disease-free survival and overall survival with age and primary metastases in patients with breast cancer. J Isfahan Med Sch. 2013;31(225):112-20.[In Persian].
43. Fazeli Z, Najafian-Zade M, Eshrati B, Almasi-Hashiani A. Five-year evaluation of epidemiological, geographical distribution and survival analysis of breast cancer in Markazi Province, 2007-11. J Arak Univ Med Sci. 2014;16(80):72-9.
44. Fardmal J, Mafi M, Sadighi-Pashaki A, Karami M, Roshanaei G. Factors affecting survival in breast cancer patients referred to the darol aitam-e mahdieh center. J Zanjan Univ Med Sci. 2013;22(93):105-15.[In Persian].
45. Salehi M, Gohari M, Vahabi N, Zayeri F, Yahyazadeh S, Kafashian M. Comparison of artificial neural network and cox regression models in survival prediction of breast cancer patients. J Ilam Univ Med Sci. 2013;21(2):120-8.[In Persian].
46. Bakhtiari A, Hajian K. Five year disease-free survival rate in breast cancer patients in Rajaii Hospital, Babolsar. J school pub health. 2007;5(2):53-9.[In Persian].
47. Khadivi R, Harrirchi I, Akbari M. Ten year breast cancer screening and follow up in 52200 women in Shahre-Kord, Iran (1997-2006). Iran J Cancer Prev.2008;1(2):73-7.
48. Akbari A, Akbari M, Khaymzadeh M, Khoshnevis S, Nafisi N. Five and ten years survival in breast cancer patients mastectomies vs. breast conserving surgeries personal experience. Iran J Cancer Prev. 2008;1(2):53-6.
49. Rezaianzadeh A, Peacock J,Reidpath D, Talei A, Hosseini S, Mehrabani D. Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran. BMC Cancer. 2009;5(9):168.
50. Heydari T, Mehrabani D, Tabei S, Azarpira N, Vakili M. Survival of breast cancer in southern Iran. Iran J Cancer Prev. 2012;2(1):51-4.
51. Gohari M, Mahmoudi M, Mohammed K, Pasha Y, Khodabakhshi R. Disease free survival and metastases pattern in breast cancer patients after mastectomy: An application of stratified Markov model. Int J Cancer Res. 2006;2:8-10.
52. Vahdaninia M, Montazeri A. Breast cancer in Iran: a survival analysis. Asian Pac J Cancer Prev. 2004;5(2):223-5.
53. Ghavam-Nasiri M, Anvari K, Nowferesti G, Silanian-Toosi M. Locally advanced breast cancer: An experience in Mashhad, North-East of Iran, 1995-1999. Arch Iranian Med. 2005;8(3):206-10.
54. Mosavi Naeeini S, Mofid B, Mohebbi H, Mehmannavaz M, Khushini S. Comparison of local recurrence, metastasis and survival between the two surgical methods for the treatment of clinical stage I and II breast cancer. kowsar med J. 2009;14(2):89-94.[In Persian].
55. Rajaeifard A, Talei A, Baneshi M. Survival analysis models for breast cancer patients in Shiraz, 1993-2002. J Med Res. 2005;3(4):41-50.
56. Asadzadeh Vostakolaei F, Broeders MJ, Rostami N, Van Dijck Jos A, Feuth T, Kiemeney Lambertus A, et al. Age at diagnosis and breast cancer survival in iran. Int J Breast Cancer. 2012:8. file:///C:/Users/dd/Downloads/517976.pdf.
57. Akbari M, Khayamzadeh M, Zeinali Z, Mohammadi G, Hadizadeh M, Samsami M, et al., editors. Breast Cancer in Iran; from Epidemiology, Clinicopathological and Biomarker Feature. 7th breast cancer congress 2014; Iran: Breast Cancer Research Centre.
58. Hedayati Godarzi A, Hedayati F, Mokarram GZ, Hedayati A, editors. Management of breast cancer during pregnancy and review of 23 treated cases in our clinic and Ostad alinasab hospital in Tabriz (north west of Iran). 7th breast cancer congress 2014; Iran: Breast Cancer Research Centre.
59. Yavari P, Mosavizadeh M, Sadrol-Hefazi B, Mehrabi Y. Reproductive characteristics and the risk of breast cancer-a case-control study in Iran. Asian Pac J Cancer Prev. 2005;6(3):370-75.
60. Ebrahimi M, Vahdaninia M, Montazeri A. Risk factors for breast cancer in Iran: a case-control study. Breast Cancer Res. 2002;4(5):1-4.
61. Fathinajafi T, Jabarzadehgangeh S, Mojahedirezaeian S, Mazlom S. Assessment of Certain Breast Cancer Risk Factors During Reproductive Age in Women in Mashhad(2002-2003). Iran Med J. 2004;42:577-85.
62. Pesaran Z, Rezaei A, Tavakoloi R, Siadat A. Evaluation of breast cancer risk factors for using in hormone replacement therapy of corticosteroid- treated post-menopausal women. Shahrekord Univ Med Sci. 2003;2(5):70-5 [In Persian].
63. Talei A, Sadeghi-Hassanabadi A, Saalabian J, al. e. A preliminary report on breast cancer screening program in Shiraz southern Iran. Iran J Med Sci. 1997;22:148.
64. Assadi K, Ovjee M, Vahdat S, Shams S, Hghshenas M, Poursalimi S. Breast cancer screening in Bushehr port population aged 30-65 years.South Med J. 1998;1:217-22.
65. Dabiri S, Sedighi B. Sensitivity and specificity of FNA in women breast mass. Hamadan Med J. 2002;9(2):5-10 [In Persian].
66. Naderi T, Bahrampoor A. Determination of sensitivity and specificity of breast tumor diagnosis by health care auxillaries (Behvarz). Kerman Med J. 2000;7(2):73-8 [In Persian].
67. Omranpoor R, Haghshenas S, Guiti M. Efficacy of axillary ultrasonography in preoperatine evaluation of nodal metastases in breast cancer. Tehran Med J. 2003;61(5):359-63 [In Persian].
68. Modir A, Mirshamsi M, Hashemian M. FNA in breast tumors and compare with gross pathology. Yazd Med J. 2001;9:28-31 (Persian).
69. Hasaniesfahani M, Mousavi S, Azargashb A. Efficacy of FNA for detecting Breast mass. Pejouhandeh. 2001;6:527-29 (Persian).
70. Abbasalizadeh S, Abbasalizadeh F, Sahaf F, Navaei N. Pre-valence of breast cancer in north west of Tabriz. Iranian J Obstetr Gyn. 2002;5:54-7.
71. Zakavi S, Mehrabibahar M, Hadadiaval M. Efficacy of breast scan with TC-MIBI for breast mass detection. Mashhad Med J. 2004;47:141-36 [in Persian].
72. Jokar F, Ghyasi N. Knowledge, attitude and practice of Ilamoan women about breast cancer. Ilam Med J. 2000;9:29-34 [In Persian].
73. Ramezani Tehrani F, Kazem M, Baroti E. Knowledge, attitude and practice of Iranian women 20-49 years old on Breast Cancer. Teb Tazkiyeh. 2001;42:30-7 [In Persian].
74. Dadkhah B, Mohammadi M. Knowledge, attitude and practice of Ardebilian women about BSE in 2001. Ardebil Med J. 2002;1:15-20 [In Persian].
75. Abedzadeh M, Sadat Z, Saberi F. Knowledge, attitude and practice of women who refer to rural health centers of Kashan about breast cancer and its case findings methods in 2001. Feiz Med J. 2003;7:85-92 [In Persian].
76. Haji-Mahmoodi M, Montazeri A, Jarvandi S, Ebrahimi M, Haghighat S, Harirchi I. Breast self-examination: knowledge, attitudes, and practices among female health care workers in Tehran, Iran. Breast J. 2002;8:222-5.
77. Mahori K, Sadeghi Hasanabadi A, Talei A. Knowledge and practice of women who refer to rural health centers of Shiraz about breast cancer screening. Hormozgan Med J. 2003;7. [In Persian].
78. Harirchi I, Ghaem-Maghami F, Karbakhsh M, Moghimi R, Mazaheri H. Patient delay in women presenting with advanced breast Cancer, a study from Iran. Pub Health. 2005;119:885-91.
79. Nafissi N SM, Motamedi MK, Akbari ME. A survey of breast cancer knowledge and attitude in Iranian women. J Can Res Ther. 2012;8:46-9.
80. Almasinokiani F, Akbari H, Madani S, Izadi B, Emami A. Incidence of breast sample pthology reports in iran(Kermanshah)2001-2004. J Kermanshah Univ Med Sci. 2005;8(2):28-3.[In Persian].
81. Montazeri A, Vahdaninia M, Harirchi I, Harirchi A, Sajadian A, Khaleghi F, et al. Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med. 2008;7(1):6.
82. Ba Eradeh N, Mirzaei M, Zamani M. Epidiomiology of Breast Cancer on Khurasan razavi in 2008. Med J Mashad Univ Med Sci. 2014;57(8):926-31.[In Persian].
83. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123(3):627-35.[In Persian].
84. (EBCTCG)* EBCTCG. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10801 women in 17 randomised trials.Lancet. 2011;378(9804):16-1707.
85. Demers AA, Turner D, Mo D, Kliewer EV. Breast cancer trends in Manitoba: 40 years of follow-up. Chronic Dis Can. 2005;26(1):13-9.
86. Fisch T, Pury P, Probst N, Bordoni A, Bouchardy C, Frick H, et al. Variation in survival after diagnosis of breast cancer in Switzerland. Ann Oncol. 2005;16:1882-8.
87. Ben Gobrane H, Fakhfakh R, Rahal K, Ben Ayed F, Maalej M, Ben Abdallah M, et al. Breast cancer prognosis in Salah Azaiez Institute of Cancer, Tunis. East Mediterr Health J. 2007;13:309-18.
88. Takahashi H, Watanabe K, Takahashi M, Taguchi K, Sasaki F, Todo S. The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer. Breast Cancer. 2005;12:196-202.
89. Marrazzoa A, Taormina P, David M, Riili I, Casa L, Catalano F, et al. Survival of breast cancer patients, Our experience. Chir Ital. 2007;59:313-8.
90. Cancer Information services: American cancer society. 2016 [cited 01/15/2016]. Available from: http://www.cancer.org/cancer/breastcancer
91. Bradshaw P, Ibrahim J, Khankari n, Cleveland R, Abrahamson P, Stevens J, et al. Post-diagnosis physical activity and survival after breast cancer diagnosis: The long island breast cancer study. Breast Cancer Res Treat. 2014;145:735-42.
92. Williams P. Significantly greater reduction in breast cancer mortality from post-diagnosis running than walking. Int J Cancer. 2014;135:1195-202.
93. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol. 2001;2(3):133-40.
94. Jaffari E, Pourshams A, Khademi H, Sajadi A, Fazel A, Gogalani G, et al. Report on the first phase of 50,000 Golestan cohort, prospective study of risk factors for cancer and other chronic diseases in the North East of Iran. Diges J. 2010;14(1):7-14.
95. Shafieezadeh T, Holakuei Naieni K, Fotohi A, Mahmoodi M. Familial aggregation of esophageal cancer in Babol district in the north of Iran. sjsph. 2006;4(1):57-64.
96. Shafigh E, Siadati S, Shefaei S. The epidemiological study of cancer in hospitals of Babol Medical University, 1990-2002. J Babol Univ Med Sci. 2005;7(3):73-8. [In Persian]
97. Yang M, Rong T, Huang Z, Zeng C, Long H, Fu J, et al. Clinical analysis of resectable breast cancer: a report of 6263 cases. Ai Zheng J. 2005 Mar;24:327-31.
98. Karimi H, Sam S. Effect of breast self-examination (BSE) education on increasing women’s knowledge and practice, Ramsar. J Babol Univ Med Sci. 2005;7(3):61-8.
99. American Cancer Society. breast cancer facts & figures 2013-2014.: American Cancer Society, Inc.; 2013 [cited 2014 March 9]. Available from: http://www.cancer.org/acs/groups/content@research/documents/document/acspc-042725.pdf/.
100. Hussain S, Altieri A, Sundquist J, Hemminiki K. Influence of education level on breast cancer risk and survival in Sweden between 1990 and 2004. Int J Cancer. 2008;122(1):165-9.
101. Li C. Breast cancer epidemiology: Springer; 2010. p. 401
102. Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F. Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer. 2006;119(10):2417-22.
103. YektaKooshali MH, Esmaeilpour-Bandboni M, Ramezani A. Scientific outputs of researchers in the field of ethics of health services in iran in the web of sciences during 2008-2015 as the scientific structure mapping. 4th Iran Med Ethics congress, Tehran. 2016:493. [In Persian]
104. YektaKooshali MH, Esmaeilpour-Bandboni M, Ramezani A. The scientific production and scientific mapping of world researchers in radiotherapy in iran during 1999 - 2015 in web of sciences. 1st National Congress of Paramedical Students. Poster 3-75 Available from: https://scholar.google.com/citations?view_op=view_citation&hl=en&user=jBw15MoAAAAJ&citation_for_view=jBw15MoAAAAJ:GnPB-g6toBAC